Диссертация (1139499), страница 49
Текст из файла (страница 49)
– P.123-133.492. Rothwell PM. Limitation of the usual blood pressure hypothesis and importanceof variability, instability, and episodic hypertension./ Rothwell PM. // Lancet. – 2010. –Vol.375(9718). – P.938-48.493. Routledge FS. Sex differences in the endothelial function of untreatedhypertension./ Routledge FS [et al]// J Clin Hypertens (Greenwich). – 2012. –Vol.14(4).
– P.228-35494. Rowland M. Blood pressure levels and hypertension in persons aged 6-94 years:United States, 1976-1980./ Rowland M, Roberts J. // Adv Data. – 1982. – Vol.84. – P.111.495. Ruelope L.M. Renal function and intensive lowering of blood pressure inhypertensive participants of the hypertension optimal treatment (HOT) study/ RuelopeL.M. [et al] // J Am Soc Nephrol. – 2001. – № 12. – P.
218-225.496. Sabogal J. C. Leptin in obstetrics and gynecology: a review./ Sabogal J. C.,Munoz L. // Obstet Gynecol Surv. – 2001. – Vol.56(4). – P.225-230.497. Safar ME. Hypertension in women./ Safar ME, Smulyan H. // Am J Hypertens. –2004. – Vol.17. – P.82–7.302498. Sampson AK. Enhanced angiotensin II type 2 receptor mechanisms mediatedecreases in arterial pressure attributable to chronic low-dose angiotensin II in femalerats./ Sampson AK [et al]// Hypertension.
– 2008. - Vol.52. – P.666–671.499. Savage D. The Spectrum of Left Ventricular Hypertrophy in a General PopulationSample: The Framingham Study./ Savage D, [et al]// Circulation. – 1987. –Vol.75(suppl I). – P.1–8.500. SawathiparnichP.SpironolactoneAbolishestheRelationshipbetweenAldosterone and Plasminogen Activator Inhibitor-1 in Humans./ Sawathiparnich P.
[etal]// J Clin Endocrinol Metab. – 2002. – Vol.87. – P.448-452.501. Scantlebury DC. Why are women more likely than men to develop heart failurewith preserved ejection fraction?/ Scantlebury DC, Borlaug BA.// Curr Opin Cardiol. –2011. – Vol.26(6). – P.562-8.502. Schenck-Gustafsson K. Risk factors for cardiovascular disease in women:assessment and management./ Schenck-Gustafsson K. // Eur Heart J. - 1996. - №17. P.2-8.503.
Schriock E.D. Divergent correlations of circulating dehydroepiandrosteronesulfate and testosterone with insulin levels and insulin receptor binding./ Schriock E.D.[et al]// J Clin Endocrinol Metab. – 1988. – Vol.66. – P.1329 –31.504. Schulman IH. Surgical menopause increases salt sensitivity of blood pressure./Schulman IH [et al]// Hypertension. – 2006.
– Vol.47(6). – P.1168-74.505. Schunkert H. Effects of oestrogen replacement therapy on the renin-angiotensinsystem in postmenopausal women/ Schunkert H.[et al]/ // Circulation. – 1997. – Vol.95. - №1. – P.39-45.506. Schunkert H. Relation between dehydroepiandrosterone sulfate and bloodpressure levels in a population-based sample./ Schunkert H.
[et al]// Am J Hypertens. –1999. – Vol.12. – P.1140 –1143.507. Schwartz JC. Histaminergic transmission in the mammalian brain./ Schwartz JC[et al]// Physiol Rev. – 1991. – Vol.71. – P.1-51.303508. Sealey J.E. Estradiol and progesterone related increases in renin-aldosteronsystem during ovarian stimulation and early pregnancy./ Sealey J.E.
[et al]// J ClinEndocr Metab. – 1994. – Vol.79(1). – P.258-64.509. Seeland U. Sex and gender differences in cardiovascular drug therapy./ SeelandU, Regitz-Zagrosek V.// Handb Exp Pharmacol. – 2012. – Vol.214. – P.211-36.510. Seeman T.E. Aging and hypothalamic-pituitary-adrenal response to challenge inhumans./ Seeman T.E., Robbins R.J.// Endocrine Reviews. – 1994. – Vol.15.
– P.233–60511. Selvin E. Androgens and diabetes in men/ Selvin E [et al] // Diabetes Care. 2007. – Vol.30. – P.234 –238.512. Sierra-Johnson J. Relation of increased leptin concentrations to history ofmyocardial infarction and stroke in the United States population./ Sierra-Johnson J [etal]// Am J Cardiol. – 2007. – Vol.100. – P.234–9.513. Simão AN. Immunological and biochemical parameters of patients withmetabolic syndrome and the participation of oxidative and nitroactive stress./ Simão AN[et al]// Braz J Med Biol Res.
– 2011. – Vol.44(7). – P.707-12.514. Simoncini T. Non-genomic actions of sex steroid hormones./ Simoncini T.,Genazzani A.R.// Eur J Endocrinol. – 2003. – Vol.148. – P.281-92.515. Singh J.P. Reduced Heart Rate Variability and New-Onset Hypertension. InsightsInto Pathogenesis of Hypertension: The Framingham Heart Study/ Singh J.P. [et al] //Hypertension.
- 1998. – Vol.32. – P.293-297.516. Singh Kh.D. Gender Specific Association of RAS Gene Polymorphism withEssential Hypertension: A Case-Control Study./ Singh Kh.D [et al]// BioMed ResearchInt. – 2014. - Article ID 538053. - 10 p.517. Singh P. Leptin upregulates the expression of plasminogen activator inhibitor-1 inhuman vascular endothelial cells./ Singh P.
[et al]// Biochem Biophys Res Commun. –2010. – Vol.392(1). – P.47–52.518. Siragy HM. The subtype 2 (AT2) angiotensin receptor mediates renal productionof nitric oxide in conscious rats./ Siragy HM, Carey RM.// J Clin Invest. – 1997. –Vol.100. – P.264-9.304519. Skurk T. Relationship berwen IL-6, leptin and adiponectin and variables offibrinolysis in overweight and obese hypertensive patients./ Skurk T [et al]// HormMetab Res.
– 2002. – Vol.34(11-12). – P.659-63.520. Smiley DA. Estrogenic compounds, estrogen receptors and vascular cell signalingin the aging blood vessels./ Smiley DA, Khalil RA.// Curr Med Chem. – 2009. –Vol.16. – P.1863-87.521. Smith G. Elevated serum creatinine and increased mortality in women and elderlyheart failure patients/ Smith G., Radford M.// J Am Coll Cardiol. – 2002. – Vol. 39. –№5. – P.
441A.522. Smulyan H. Comparative effects of aging in men and women on the properties ofthe arterial tree./ Smulyan H [et al]// J Am Coll Cardiol. – 2001. –Vol.37. – P.1374 –1380.523. Soderberg S. Plasma leptin levels are associated with abnormal fibrinolysis inmen and postmenopausal women./ Soderberg S [et al]// J Intern Med. – 1999. –Vol.245.– P.533–43.524. Somjen D. Effects of gonadal steroids and their antagonists on DNA synthesis inhuman vascular cells./ Somjen D [et al]// Hypertension.
– 1998. –Vol.32. – P.39–45.525. SorannoD.Hypertensionandvirilizationcausedbyauniquedexoxycorticosterone and androgen-secreting adrenal adenoma./ Soranno D [et al]// JPediatr Endocrinol Metab. – 1999. – Vol.12. – P.215-220.526. SowersJ.R.Hyperinsulinemia,insulinresistanceandhyperglycemia:contributing factors in pathogenesis of hypertension and atherosclerosis./ Sowers J.R.[et al]// Am J Hypertens. – 1993. – Vol.6. – P.S260-70.527. Sowers MFR. Androgens are associated with hemostatic and inflammatoryfactors among women at the mid-life./ Sowers MFR [et al]// J Clin Endocrinol Met. –2005.
– Vol.90(11). – P.6064-71.528. Sowers MFR. Hemostatic factors and estrogen during the menopausal transition./Sowers MFR [et al]// J Clin Endocrinol Met. – 2005. – Vol.90(11). – P.5942-8.305529. Spencer CG. Von Willebrand factor, soluble P-selectin, and target organ damagein hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial(ASCOT)/ Spencer CG, Gurney D et al.// Hypertension.- 2002.- Vol.40.-Р.61- 6.530. Spiegelman B.
M. Adipogenesis and obesity: rounding out the big picture./Spiegelman B. M., Flier J. S.// Cell. – 1996. – Vol.87. – P.377-89.531. Spiel AO. von Willebrand factor in cardiovascular disease: focus on acutecoronary syndromes / Spiel AO, Gilbert JC, Jilma B //Circulation. - 2008. - Vol.117. Р.1449-59.532. Spoletini I. Sex differences in drug effects: interaction with sex hormones in adultlife./ Spoletini I [et al]// In: Regitz-Zagrosek V (ed) Sex and gender differences inpharmacology. - Springer, Heidelberg.
- 2012.533. Staessen J.A. The epidemiology of menopause and associated cardiovasculardisease./ Staessen J.A. [et al]// In: Hypertension after menopause. Stimpel M., ZanchettiA. (ed.). - de Gruyter, Berlin, New York. – 1997. - P.21-29.534. Staiger H. Adipocytokines: fat–derived humoral mediators of metabolichomeostasis./ Staiger H, Haring HU.// Exp Clin Endocrinol Diabetes. – 2005. –Vol.113(2). – P.67–79.535. Stampfer MJ.
Postmenopausal estrogen therapy and cardiovascular disease. Tenyear follow-up from the nurses' health study./ Stampfer MJ [et al]// N Engl J Med. –1991. – Vol.325. – P.756-762.536. Stanosz S. Excretion of free catecholomines in urine and water electrolytebalance in women with hypertension in the period before and after menopause./ StanoszS., Kuligowski D.
// Gynecol Polska. – 1992. – Vol.63(3). – P.300-303.537. Stein Ph. Differing effects of age on heart rate variability in men and women./Stein Ph., Kleiger R., Rottman J.// Am J Cardiol. – 1997. – Vol.80(3). –P.302-305.538. Stener-Victorin E. Low-frequency Electro-Acupuncture and Physical ExerciseDecrease High Muscle Sympathetic Nerve Activity in Polycystic Ovary Syndrome./Stener-Victorin E. [et al]// Am J Physiol Regul Integr Comp Physiol. - 2009.
– Vol.3306539. SudhirK.Estrogensupplementationdecreasesnorepinephrine-inducedvasoconstriction and total body norepinephrine spillover in perimenopausal women./Sudhir K. [et al]// Hypertension. – 1997. – Vol.30. – P.1538-43.540. Sulcova J. Age and sex related differences in serum levels of unconjugateddehydroepiandrosterone and its sulphate in normal subjects./ Sulcova J. [et al]// JEndocrinol. – 1997.
– Vol.154. – P.57-62.541. Sundström J. Diabetes, lipids and metabolism: Blood pressure-independentrelations of left ventricular geometry to the metabolic syndrome and insulin resistance:a population-based study./ Sundström J [et al]// Heart. – 2008. – Vol.94. – P.874-878.542.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
